Abstract
Context
Late or residual symptoms diminish quality of life for many cancer survivors after completion of treatment.
Objectives
Examine risk factors associated with persisting symptom burden after chemotherapy and the lack of symptom improvement over time.
Methods
Survivors who completed curative-intent chemotherapy within two years for solid tumors were enrolled into a symptom management trial. There were 375 survivors with two or more comorbid conditions or one comorbid condition and elevated depressive symptoms (pre-defined risk factors in the trial design) who received interventions and 71 survivors without these risk factors who did not receive interventions. For all survivors, symptoms were assessed at intake, 4, and 13 weeks and categorized as mild, moderate, or severe based on the interference with daily life. The probabilities of moderate or severe symptoms and symptom improvement were analyzed using generalized mixed-effects models in relation to comorbidity, depressive symptoms, age, sex, race/ethnicity, employment, time since chemotherapy completion, and physical function. Multiple symptoms were treated as nested within the survivor.
Results
Moderate or severe symptoms at baseline and the lack of improvement over time were associated with younger age and lower physical function over and above a greater number of comorbidities and elevated severity of depressive symptoms.
Conclusion
Risk factors identified in this research (younger age, lower physical function, greater comorbidity, and higher depressive symptoms) can be used to allocate resources for post-treatment symptom management for cancer survivors in order to relieve symptoms that do not necessarily resolve with time.
Similar content being viewed by others
References
Cleeland, C., Zhao, F., Chang, V., et al. (2013). The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the eastern cooperative oncology group symptom outcomes and practice patterns study. Cancer, 119(24), 4333–4340. https://doi.org/10.1002/cncr.28376
Portenoy, R. K., Thaler, H. T., Kornblith, A. B., et al. (1994). Symptom prevalence, characteristics and distress in a cancer population. Quality of Life Research, 3(3), 183–189.
Kim, S. H., Kim, K., & Mayer, D. K. (2017). Self-management intervention for adult cancer survivors after treatment: a systematic review and meta-analysis. Oncology Nursing Forum, 44(6), 719–728. https://doi.org/10.1188/17.ONF.719-728
Faul, L. A., Jim, H. S., Williams, C., Loftus, L., & Jacobsen, P. B. (2010). Relationship of stress managment skills to psychological distress and quality of life in adults with cancer. Psycho Oncology., 19(1), 102–109.
Jacobs, J. M., Ream, M. E., Pensak, N., et al. (2019). Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life. Journal of the National Comprehensive Cancer Network, 17(3), 221–228. https://doi.org/10.6004/jnccn.2018.7098
Ganz, P., Kwan, L., Stanton, A., Krupnick, J., Rowland, J. H., & Meyerowitz, B. (2004). Quality of life at the end of primary treatment of breast cancer: First results from the moving beyond cancer randomized trial. Journal of the National Cancer Institute, 96(5), 376–387.
Ganz, P. A., Kwan, L., Stanton, A. L., Bower, J. E., & Belin, T. R. (2011). Physical and psychosocial recovery in the year after primary treatment of breast cancer. Journal of Clinical Oncology, 29(9), 1101–1109. https://doi.org/10.1200/JCO.2010.28.8043
Post, K. E. F. J. (2016). Web based survivorship interventions for women with breast cancer: An integrative review. European Journal of Oncology Nursing, 25, 90–99. https://doi.org/10.1016/j.ejon.2016.10.004
Ferrell, B. R., Dow, K. H., & Grant, M. (1995). Measurement of the quality of life in cancer survivors. Quality of Life Research, 4(6), 523–531. https://doi.org/10.1007/BF00634747
Boivin, M. J., Sikorskii, A., Haan, P., et al. (2021). Health-related quality of life: longitudinal analysis from the time of breast biopsy into the post-treatment period. Front Glob Womens Health, 2, 608787. https://doi.org/10.3389/fgwh.2021.608787
Given, C. W., Given, B., Azzouz, F., Kozachik, S., & Stommel, M. (2001). Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. Journal of Pain and Symptom Management, 21(6), 456–466. https://doi.org/10.1016/s0885-3924(01)00284-6
Dougherty, P., Cata, J., Cordella, J., Burton, A., & Weng, H. (2004). Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain, 109, 132–142.
Mercadante, S., Casuccio, A., & Fulfaro, F. (2000). The course of symptom frequency and intensity in advanced cancer patients followed at home. Journal of Pain and Symptom Management, 20(2), 104–112.
Dupont, A., Bower, J. E., Stanton, A. L., & Ganz, P. A. (2013). Cancer-related intrusive thoughts predict behavioral symptoms following breast cancer treatment. Health Psychology. https://doi.org/10.1037/a0031131
Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer, 104(10), 2222–2233. https://doi.org/10.1002/cncr.21469
Carreira, H., Williams, R., Müller, M., Harewood, R., Stanway, S., & Bhaskaran, K. (2018). Associations between breast cancer survivorship and adverse mental health outcomes: a systematic review. Journal of the National Cancer Institute, 110(12), 1311–1327. https://doi.org/10.1093/jnci/djy177
Costa, D. S. J., & Fardell, J. E. (2019). Why are objective and perceived cognitive function weakly correlated in patients with cancer? Journal of Clinical Oncology, 37(14), 1154–1158. https://doi.org/10.1200/JCO.18.02363
Kroenke, K. (2001). Studying symptoms: Sampling and measurement issues. Annals of internal medicine, 134(9 Pt 2), 844–853.
Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273(1), 59–65.
Misono, S., Weiss, N. S., Fann, J. R., Redman, M., & Yueh, B. (2008). Incidence of suicide in persons with cancer. Journal of clinical oncology : Official journal of the American Society of Clinical Oncology, 26(29), 4731–4738.
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., et al. (2008). Major depression after breast cancer: A review of epidemiology and treatment. General hospital psychiatry, 30(2), 112–126.
Jahan, N., Cathcart-Rake, E. J., & Ruddy, K. J. (2022). Late breast cancer survivorship: side effects and care recommendations. Journal of Clinical Oncology, 40(15), 1604–1610. https://doi.org/10.1200/JCO.22.00049
Badger, T. A., Sikorskii, A., Segrin, C., Crane, T. E., & Hadeed, M. (2020). Symptom Management and Survivorship Handbook (2nd ed.). University of Arizona College of Nursing.
Korn, C. W., Sharot, T., Walter, H., Heekeren, H. R., & Dolan, R. J. (2014). Depression is related to an adsence fo optimistically baiased belief updating about future life events. Psychological Medicine, 44(3), 579–592. https://doi.org/10.1017/S0033291713001074
Dozois, D. J., & Dobson, K. S. (2001). Information processing and colgnitive organization in unipolar depression: Specificity and comorbidity issues. Journal of Abnormal Psychology, 110(2), 236–246.
Hjerl, K., Andersen, E. W., Keiding, N., Mortensen, P. B., & Jorgensen, T. (2002). Increased incidence of affective disorders, anxiety disorders, and non-natural mortality in women after breast cancer diagnosis: A nation-wide cohort study in Denmark. Acta Psychiatrica Scandinavica, 105(4), 258–264.
Zhu, L., Ranchor, A. V., van der Lee, M., et al. (2017). Co-morbidity of depression, anxiety and fatigue in cancer patients receiving psychological care. Psycho-Oncology, 26(4), 444–451. https://doi.org/10.1002/pon.4153
Bayliss, E. A., Ellis, J. L., & Steiner, J. F. (2007). Barriers to self-management and quality-of-life outcomes in seniors with multimorbidities. Annals of Family Medicine, 5(5), 395–402.
Bender, C. M., Engberg, S. J., Donovan, H. S., et al. (2008). Symptom clusters in adults with chronic health problems and cancer as a comorbidity. Oncology Nursing Forum, 35(1), E1–E11.
Das, S. C., Khurana, H., Gupta, D., Mishra, S., & Bhatnagar, S. (2009). Comorbidities in a cancer patient: Problems in pain management and palliation. The American Journal of Hospice & Palliative Care, 26(1), 60–63. https://doi.org/10.1177/1049909108322297
Gerbershagen, H. J., Ozgur, E., Straub, K., et al. (2008). Prevalence, severity, and chronicity of pain and general health-related quality of life in patients with localized prostate cancer. European journal of pain (London, England), 12(3), 339–350. https://doi.org/10.1016/j.ejpain.2007.07.006
Harlan, L. C., Klabunde, C. N., Ambs, A. H., et al. (2009). Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer. Journal of Cancer Survivorship, 3(2), 89–98. https://doi.org/10.1007/s11764-009-0084-3
Harris, E. E., Hwang, W. T., Urtishak, S. L., Plastaras, J., Kinosian, B., & Solin, L. J. (2008). The impact of comorbidities on outcomes for elderly women treated with breast-conservation treatment for early-stage breast cancer. International Journal of Radiation Oncology Biology Physics, 70(5), 1453–1459. https://doi.org/10.1016/j.ijrobp.2007.08.059
Pinkawa, M., Fischedick, K., Gagel, B., et al. (2009). Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment. BMC Cancer. https://doi.org/10.1186/1471-2407-9-296
Cleeland, C. S. (2007). Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. Journal of the National Cancer Institute Monographs, 37, 16–21. https://doi.org/10.1093/jncimonographs/lgm005
Ahern, T. P., Lash, T. L., Thwin, S. S., & Silliman, R. A. (2009). Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors. Medical Care, 47(1), 73–79. https://doi.org/10.1097/MLR.0b013e318180913c
Aschele, C., Bergamo, F., & Lonardi, S. (2009). Chemotherapy for operable and advanced colorectal cancer. Cancer treatment review., 35(6), 509–516. https://doi.org/10.1016/j.ctrv.2009.04.003
Kelly, D. (2006). Delays in the diagnosis of lung cancer occurred because patients failed to recognise symptoms as serious and warranting medical attention. Evidence-based nursing, 9(4), 127.
Miller, A. H., Ancoli-Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R. (2008). Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. Journal of Clinical Oncology, 26(6), 971–982. https://doi.org/10.1200/jco.2007.10.7805
Mukerji, S. S., Duffy, S. A., Fowler, K. E., Khan, M., Ronis, D. L., & Terrell, J. E. (2007). Comorbidities in head and neck cancer: agreement between self-report and chart review. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery., 136(4), 536–542. https://doi.org/10.1016/j.otohns.2006.10.041
Ozanne, E. M., Braithwaite, D., Sepucha, K., Moore, D., Esserman, L., & Belkora, J. (2009). Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. Journal of Clinical Oncology, 27(2), 214–219. https://doi.org/10.1200/jco.2008.17.3914
Perkins, H. Y., Baum, G. P., Taylor, C. L., & Basen-Engquist, K. M. (2009). Effects of treatment factors, comorbidities and health-related quality of life on self-efficacy for physical activity in cancer survivors. Psycho-Oncology, 18(4), 405–411. https://doi.org/10.1002/pon.1535
Siegelmann-Danieli, N., Khandelwal, V., Wood, G. C., et al. (2006). Breast cancer in elderly women: Outcome as affected by age, tumor features, comorbidities, and treatment approach. Clinical Breast Cancer, 7(1), 59–66. https://doi.org/10.3816/CBC.2006.n.014
Hewitt, M., Greenfield, S., & Stovall, E. (2005). From Cancer Patient to Cancer Survivor: Lost in Translation. The National Academies Press.
Rowland, J. H., & Yancik, R. (2006). Cancer survivorship: The interface of aging, comorbidity, and quality care. Journal of the National Cancer Institute, 98(8), 504–505. https://doi.org/10.1093/jnci/djj154
Parikh, R. B., Gallo, J. J., Wong, Y. N., et al. (2021). Long-term depression incidence and associated mortality among African American and White prostate cancer survivors. Cancer, 127(18), 3476–3485. https://doi.org/10.1002/cncr.33656
Bensken, W. P., Schiltz, N. K., Warner, D. F., et al. (2022). Comparing the association between multiple chronic conditions, multimorbidity, frailty, and survival among older patients with cancer. Journal of Geriatric Oncology, 13(8), 1244–1252. https://doi.org/10.1016/j.jgo.2022.06.011
Sikorskii, A., Badger, T., Segrin, C., et al. (2023). A sequential multiple assignment randomized trial of symptom management after chemotherapy. Journal of Pain Symptom Management, 65(6), 541-552 e2. https://doi.org/10.1016/j.jpainsymman.2023.02.005
Hjerl, K., Andersen, E. W., Keiding, N., Mouridsen, H. T., Mortensen, P. B., & Jorgensen, T. (2003). Depression as a prognostic factor for breast cancer mortality. Psychosomatics, 44(1), 24–30. https://doi.org/10.1176/appi.psy.44.1.24
Badger, T. A., Segrin, C., Hepworth, J. T., Pasvogel, A., Weihs, K., & Lopez, A. M. (2013). Telephone-delivered health education and interpersonal counseling improve quality of life for Latinas with breast cancer and their supportive partners. Psycho-Oncology, 22(5), 1035–1042. https://doi.org/10.1002/pon.3101
Badger, T. A., Segrin, C., Sikorskii, A., et al. (2020). Randomized controlled trial of supportive care interventions to manage psychological distress and symptoms in Latinas with breast cancer and their informal caregivers. Psychology & Health, 35(1), 87–106. https://doi.org/10.1080/08870446.2019.1626395
Badger, T., Segrin, C., Figueredo, A. J., Harrington, J., Sheppard, K., Passalacqua, S., Pasvogel, A., & Bishop, M. (2012). Who benefits from a psychosocial counseling vs. educational intervention to improve psychological quality of life in prostate cancer surviors. Psychology & Health. https://doi.org/10.1080/08870446.2012.731058
Bayliss, E., Ellis, J., & Steiner, J. (2009). Seniors’ self-reported multimorbidity captured biopsychosocial factors not incorporated into tow other data-based mortlity measures. Journal of Clinical Epidemiology, 62(5), 550–557.
Badger, T. A., Segrin, C., & Meek, P. (2011). Development and validation of an instrument to rapidly assess symptoms: The General Symptom Distress Scale. Journal of pain and symptom management, 41(3), 535–548.
Given, B., Given, C., Sikorskii, A., et al. (2008). Establishing mild, moderate and severe scores for cancer related symptoms: How consistent and clinically meaningful are interference based severity cut points? Journal of Pain and Symptom Management, 35(2), 126–135.
Jeon, S., GC, W., Sikorskii, A., & Given, B. (2009). Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time? Journal of Pain and Symptom Managemnt, 37(2), 220–232.
Sikorskii, A., Given, C., You, M., Jeon, S., & Given, B. (2009). Response analysis for multiple symptoms revealed differences between arms of a symptom management trial. Journal of Clinical Epidemiology, 62(7), 716–724.
Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.
Miaskowski, C., Mastick, J., Paul, S., Wallhagen, M., Abrams, G., & Levine, J. D. (2022). Associations among hearing loss, multiple co-occurring symptoms, and quality of life outcomes in cancer survivors. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-022-01301-0
Badger, T. A., Segrin, C., Crane, T. E., et al. (2023). Social determinants of health and symptom burden during cancer treatment. Nursing Research, 72(2), 103–113. https://doi.org/10.1097/NNR.0000000000000636
Schuz, N., Walters, J. A., Cameron-Tucker, H., Scott, J., Wood-Baker, R., & Walters, E. H. (2015). Patient anxiety and depression moderate the effects of increased self-management knowledge on physical activity: A secondary analysis of a randomised controlled trial on health-mentoring in COPD. COPD, 12(5), 502–509. https://doi.org/10.3109/15412555.2014.995289
Campbell, G., Hagan, T., Gilbertson-White, S., Houze, M., & Donovan, H. (2016). Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: A cross-sectional study. Gynecologic Oncology, 143(3), 578–583. https://doi.org/10.1016/j.ygyno.2016.09.013
Iovino, P., De Maria, M., Matarese, M., Vellone, E., Ausili, D., & Riegel, B. (2020). Depression and self-care in older adults with multiple chronic conditions: A multivariate analysis. Journal of Advanced Nursing, 76(7), 1668–1678. https://doi.org/10.1111/jan.14385
Ream, E., Hughes, A. E., Cox, A., et al. (2020). Telephone interventions for symptom management in adults with cancer. Cochrane Database System Review. https://doi.org/10.1002/14651858.CD007568.pub2
Deshields, T. L., Potter, P., Olsen, S., & Liu, J. (2014). The persistence of symptom burden: Symptom experience and quality of life of cancer patients across one year. Supportive Care in Cancer, 22(4), 1089–1096. https://doi.org/10.1007/s00520-013-2049-3
Cataldo, J. K., Paul, S., Cooper, B., et al. (2013). Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study. BMC Cancer. https://doi.org/10.1186/1471-2407-13-6
Hansen, M. B., Ross, L., Petersen, M. A., & Groenvold, M. (2022). Age, cancer site and gender associations with symptoms and problems in specialised palliative care: A large, nationwide, register-based study. BMJ supportive & palliative care, 12(e2), e201–e210. https://doi.org/10.1136/bmjspcare-2019-001880
Fredholm, H., Magnusson, K., Lindström, L. S., et al. (2016). Long-term outcome in young women with breast cancer: A population-based study. Breast Cancer Research and Treatment, 160(1), 131–143. https://doi.org/10.1007/s10549-016-3983-9
Farrar, J. T., Portenoy, R. K., Berlin, J. A., Kinman, J. L., & Strom, B. L. (2000). Defining the clinically important difference in pain outcome measures. Pain, 88(3), 287–294.
Miaskowski, C., Dodd, M., West, C., et al. (2007). The use of a responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain management. Pain, 129(1–2), 55–63. https://doi.org/10.1016/j.pain.2006.09.031
Sikorskii, A., Niyogi, P. G., Victorson, D., Tamkus, D., & Wyatt, G. (2020). Symptom response analysis of a randomized controlled trial of reflexology for symptom management among women with advanced breast cancer. Supportive Care in Cancer, 28(3), 1395–1404. https://doi.org/10.1007/s00520-019-04959-y
Given, C., Given, B., Rahbar, M., et al. (2004). Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. Journal of Clinical Oncology., 22(3), 507–516.
Runowicz, C. D., Leach, C. R., Henry, N. L., et al. (2016). American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. Jan-Feb, 66(1), 43–73. https://doi.org/10.3322/caac.21319
Penedo, F. J., Medina, H. N., Moreno, P. I., et al. (2022). Implementation and feasibility of an electronic health record-integrated patient-reported outcomes symptom and needs monitoring pilot in ambulatory oncology. JCO Oncol Pract. https://doi.org/10.1200/OP.21.00706
Basch, E., Barbera, L., Kerrigan, C. L., & Velikova, G. (2018). Implementation of patient-reported outcomes in routine medical care. American Society of Clinical Oncology Educational Book, 38, 122–134. https://doi.org/10.1200/EDBK_200383
Tam, S., Zatirka, T., Neslund-Dudas, C., et al. (2023). Real time patient-reported outcome measures in patients with cancer: Early experience within an integrated health system. Cancer medicine. https://doi.org/10.1002/cam4.5635
Corser, W., Sikorskii, A., Olomu, A., Stommel, M., Proden, C., & Holmes-Rovner, M. (2008). Concordance between comorbidity data from patient self-report interviews and medical record documentation. BMC Health Services Research. https://doi.org/10.1186/1472-6963-8-85
Ye, F., Moon, D. H., Carpenter, W. R., et al. (2017). Comparison of patient report and medical records of comorbidities: results from a population-based cohort of patients with prostate cancer. JAMA Oncology, 3(8), 1035–1042. https://doi.org/10.1001/jamaoncol.2016.6744
Bayliss, E. A., Ellis, J. L., & Steiner, J. F. (2009). Seniors’ self-reported multimorbidity captured biopsychosocial factors not incorporated into two other data-based morbidity measures. Journal of Clinical Epidemiology, 62(5), 550–7 e1. https://doi.org/10.1016/j.jclinepi.2008.05.002
Hall, E. T. S. S., Dickerson, J., Gaster, B., Wong, H., Aslaskson, R. A., & Schapira, L. (2019). Patient reported outcomes for cancer patients receiving immunotherapy: opportunies for palliative care- A systematic review. Jouranl of Pain and Symptom Management. https://doi.org/10.1200/JCO.2017.77.6385
Brahmer, J. R. L. C., Schneider, B. J., Atkins, M. B., Brassil, K. J., Caterino, J. M., Cau, I., Ernstoof, M. S., Gardner, J. M., Ginex, P., & Hallmeyer, S. (2018). Treated with immune checkpoint inhibior thearapy: American society of clinical oncology practice guideline. Journal of Clinical Oncology, 36(17), 1714–1768. https://doi.org/10.12000/JCO.2017.77.6385
Funding
This study was supported by a supplement to an R01 grant from the National Institutes of Health, Post-chemotherapy Symptom Management: Testing Intervention Sequences in a SMART Design (R01 CA225615-01). MPIs: T. Badger/A. Sikorskii. Data were collected using the Behavioral Intervention and Measurement Shared Resource at the University of Arizona Cancer Center (P30 CA023074).
Author information
Authors and Affiliations
Contributions
Conceptualization: AS, TB, CS, TC, and CG. Data curation: AS, TB, CS, TC, PC, and WA. Formal Analysis: AS and NC. Methodology: AS, TB, CS, TC, and CG. Supervision: TB, CS, and AS. Writing of the original draft: AS, TB, and CS. Writing, reviewing, & editing of the manuscript: all authors. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Data availability
We will share the data upon request made to first author (Alla Sikorskii) based on the principles that NIH has articulated regarding sharing of study results and resources. Data from this study will be available to other researchers and key stakeholders under the following conditions: 1) appropriate human subjects protection is in place; 2) data have been de-identified; and 3) study investigators have publicly presented and published key findings.
Code availability
SAS code used to produce the results is available upon request made to the first author (Alla Sikorskii).
Ethical approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of the University of Arizona, protocol number Protocol 1711069340.
Consent to participate
Informed consent was obtained from all participants of the study.
Consent for publication
The manuscript does not contain any individual personal data. All data are presented on aggregate so that no individual can be identified.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sikorskii, A., Badger, T., Segrin, C. et al. Predictors of persistence of post-chemotherapy symptoms among survivors of solid tumor cancers. Qual Life Res 33, 1143–1155 (2024). https://doi.org/10.1007/s11136-023-03595-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-023-03595-8